|
a-BuTX/Tx |
a-bungarotoxin |
|
A |
anterior (brain co-ordinate: A3, etc.) |
|
A |
absorbance |
|
A23187 |
a calcium ionophore |
|
A7r5 |
smooth muscle cells from embryonic rat aorta |
|
aNa1, ai Na |
intracellular sodium activity |
|
Ab |
antibody |
|
ABC |
avidin–biotin complex |
|
9-AC |
anthracene-carboxylic acid |
|
ACE potential |
average common excitatory potential |
|
ACSF |
artificial cerebrospinal fluid |
|
AChE |
acetylcholinesterase |
|
AChR |
acetylcholine receptor |
|
ACTH(1–24) |
a specific peptide fragment of ACTH ( ...the peptide ACTH in titles) |
|
ACT |
Australian Capital Territory (no stops) |
|
ADH |
antidiuretic hormone (vasopressin) v-Aga IVA v-agatoxin (from funnel web spider) |
|
AH cell |
(after-) afterhyperpolaris(z)ation cell |
|
AHP |
(after-) afterhyperpolaris(z)ation |
|
AMP-PNP |
adenylyl imidophosphate |
|
4-AP |
4-aminopyridine |
|
AP III |
antipyrylazo III |
|
AP4 |
2-amino-4-phosphonobutyric acid |
|
APV/AP5 |
D-aminophosphonovalerate; also DL-2-amino-5-phosphonovaleric acid |
|
ASW |
artificial sea water |
|
ATCC |
American Type Culture Collection |
|
a.u. |
arbitrary unit |
|
a–v |
arteriovenous |
|
β |
buffering capacity |
|
Bmax |
maximal binding |
|
BAPTA AM |
acetoxymethyl ester form of BAPTA |
|
BCECF |
pH-sensitive dye: (2‚,7‚-bis(carboxyethyl)-5-carboxyfluorescein/2‚,7‚-bis(carboxyethyl)-6-carboxyfluorescein) |
|
BCECF AM |
the acetoxymethyl ester form |
|
BHKC |
baby hamster kidney cell line |
|
BP |
blood pressure |
|
BP |
British pharmacopoeia |
|
8-Br-cAMP |
8-bromoadenosine 3‚,5‚ cyclic monophosphate |
|
8-Br-cGMP |
8-bromoguanosine 3‚,5‚ cyclic monophosphate |
|
BSA |
bovine serum albumin |
|
BTPS |
body temperature and pressure when saturated with water vapour |
|
α-BuTX/Tx |
a-bungarotoxin |
|
C |
capacitance |
|
Ca2+–CaM |
Ca 2+–calmodulin complex |
|
CaM |
calmodulin |
|
CaMKII |
calmodulin-dependent protein kinase II |
|
CCCP |
carbonyl cyanide m-chlorophenylhydrazone |
|
CCh |
carbachol (carbamylcholine chloride) |
|
CCK |
cholecystokinin |
|
CCK8 or CCK-8 |
cholecystokinin octapeptide |
|
CF |
cystic fibrosis |
|
CGRP |
calcitonin gene-related peptide v-CgTX/Tx v-conotoxin (from Conus geographus) |
|
CHAPS |
3-[(3-cholamidopropyl)dimethylammonio]-1-propane sulphonate |
|
ChAT |
choline acetyltransferase |
|
ChE |
cholinesterase |
|
CHO |
carbohydrate |
|
CHO |
Chinese hamster ovary (cell line) |
|
CICR |
calcium-induced calcium release (also Ca2+-induced Ca2+ release) |
|
CFTR |
cystic fibrosis transmembrane conductance regulator |
|
CNQX |
6-cyano-7-nitroquinoxaline-2,3-dione |
|
CoA |
coenzyme A |
|
ConA |
concanavalin A |
|
COS |
African green monkey kidney cells |
|
CP |
(CrP) creatine phosphate |
|
CRF |
corticotrop(h)in-releasing factor |
|
CRH |
corticotrop(h)in-releasing hormone |
|
CSF |
cerebrospinal fluid |
|
CTX |
charybdotoxin (scorpion venom) |
|
c.v. or CV |
coefficient of variation |
|
D600 |
methoxyverapamil |
|
DAB |
diaminobenzidine |
|
DADLE |
D-alanine-D-leucine-enkephalin |
|
DAG |
1,2-diacylglycerol (see also DG); also 1,2-sn-diacylglycerol |
|
dATP |
deoxyATP |
|
dB-cAMP |
dibutyryl cAMP |
|
D–C coupling |
depolarization–contraction coupling |
|
d.f. |
degrees of freedom |
|
1DI |
first dorsal interosseus muscle (also FDI) |
|
DI |
diabetes insipidus |
|
DIC |
differential interference contrast (DIC microscope; also called ‘Nomarski optics’) |
|
dLGN |
dorsal lateral geniculate nucleus |
|
DMEM |
Dulbecco’s modified Eagle’s medium |
|
DNFB |
2,4-dinitro-1-fluorobenzene (Sanger’s reagent; same as FDNB) |
|
DNP |
dinitrophenol |
|
DNQX |
6,7-dinitro-quinoxaline-2,3-dione |
|
L-DOPA |
L-3,4-dihydroxyphenylalanine |
|
DPhil |
(Oxford and Sussex) |
|
Dr |
doctor |
|
DRG |
dorsal root ganglion |
|
dTC |
d-tubocurarine (note roman ‘d’ in abbreviation) |
|
DTT |
dithiothreitol |
|
DTX |
dendrotoxin |
|
E- |
indicates molecular configuration |
|
E |
equilibrium potential (use Vfor other potentials) |
|
EK |
equilibrium potential for potassium |
|
Em |
membrane potential (Vm preferred) |
|
eag |
ether-`a-go-go (Drosophila gene) |
|
ECACC |
European Collection of Animal Cell Cultures |
|
E–C |
coupling excitation–contraction coupling |
|
ECoG |
electrocorticogram |
|
EDL |
extensor digitorum longus |
|
EDRF |
endothelium-derived relaxing factor |
|
EJP |
excitatory junction potential |
|
ELISA |
enzyme-linked immunosorbent assay |
|
EOG |
electro-oculogram |
|
EPP |
endplate potential |
|
ERG |
eletroretinogram |
|
F |
Faraday’s constant |
|
F340 |
fluorescence intensity with 340 nm excitation |
|
FI,CO2 |
inspired CO2 fraction (also FI,J) |
|
FCR |
flexor carpis radialis |
|
FDI |
first dorsal interosseus (also 1DI) |
|
FDNB |
1-fluoro-2,4-dinitrobenzene (same as DNFB) |
|
FENa |
fractional sodium excretion |
|
FF |
fast-fatigable (muscle) |
|
FFA |
free fatty acids |
|
FFT |
fast Fourier transform |
|
FITC |
fluorescein isothiocyanate |
|
FM |
frequency modulation |
|
FR |
fatigue-resistant (muscle) |
|
FSH |
follicle-stimulating hormone |
|
FW |
formula weight (sum of atomic weights); occasionally given instead of MW; see Sigma catalogue |
|
FWHM |
full width at half-maximum (standard abbreviation for optical instruments) |
|
g |
acceleration due to gravity |
|
g or G |
electrical conductance (make consistent within the paper) |
|
G |
thermal conductance |
|
G |
universal constant of gravitation (N m2 kg_2) |
|
GFP |
green fluorescent protein |
|
GFR |
glomerular filtration rate |
|
GH3 cell |
clonal pituitary cell |
|
GHK |
Goldman-Hodgkin-Katz (GHK equation) |
|
GIP |
gastric inhibitory peptide |
|
Glc |
glucose (Glu = glutamate) |
|
GLC |
gas-liquid chromatography |
|
GLUT2/GLUT-2 |
glucose transporter 2 |
|
GMT |
Greenwich mean time |
|
G-6-P |
glucose 6-phosphate (only one hyphen in full) |
|
h |
inactivation parameter (also hW; in GHK equation) |
|
H & E |
H(h)aematoxylin and E(e)osin |
|
Hct |
haematocrit |
|
HDTA |
1,6-diaminohexane-N,N,N‚,N ‚-tetraacetic acid |
|
HEK 293 |
human embryonic kidney cell line |
|
HeLa cells |
cell line taken from Henrietta Lacks alias Helen Lane |
|
HERG/HERG |
human ether-`a-go-go related gene/protein |
|
HP |
holding potential (Vh or VH) |
|
HR |
heart rate |
|
5-HT1/1A/2/3 |
5-HT receptor types |
|
I or i |
current or single-channel current |
|
|
calcium-activated K+ current: IK(Ca) or IK,Ca |
|
|
calcium-release activated calcium current: ICRAC |
|
|
delayed rectifier K+ current: IK(V) |
|
|
slow calcium-activated K+current: IAHP |
|
|
short-circuit current: ISC |
|
|
slow inward current: ISI |
|
|
transient outward current: ITO |
|
|
transient outward K+ current: IA |
|
|
fast calcium current: iCa,f |
|
|
slow calcium current: iCa,s |
|
IBMX |
3-isobutyl-1-methylxanthine |
|
I.C. |
intracarotid (small capitals) also intracardiac (small capitals) |
|
I.C.V. |
intracerebroventricular (small capitals) |
|
IJP |
inhibitory junction potential |
|
IL-1 |
interleukin-1 |
|
IL-2 |
interleukin-2 (cell growth factor) |
|
Inc. |
incorporated (note stop; cf. Ltd) |
|
InsP2 |
inositol 4,5-bisphosphate (bis- not bi-) |
|
InsP4 |
inositol 1,3,4,5-tetrakisphosphate |
|
InsP3/IP3 |
inositol 1,4,5-trisphosphate (tris- not tri-) |
|
ISE |
ion-selective electrode (see RLIE) |
|
JNai |
intracellular sodium flux |
|
Jv |
proximal tubular fluid resorption volume |
|
KA |
kainate (allowed in titles as part of AMPA/KA) |
|
KB medium |
(Kraft-Brühe medium) |
|
KVLQT1/KvLQT1 |
K+ channel protein |
|
L cell |
mouse cell line |
|
L0 |
initial muscle length |
|
Lo |
optimum muscle length |
|
Lp |
hydraulic conductivity |
|
LD50 |
median (or half-maximal) lethal dose |
|
LDH |
lactate dehydrogenase |
|
LDL |
low-density lipoprotein |
|
LED |
light-emitting diode |
|
LH |
luteinizing hormone |
|
LHRH |
luteinizing hormone-releasing hormone |
|
L-NMMA |
NG-monomethyl-l-arginine |
|
L-NNA |
N G-nitro-L-arginine |
|
LTP |
long-term potentiation |
|
M1, M2 (m1, m2) |
muscarinic receptors |
|
Mr |
relative molecular mass (use symbol or rel. mol. mass; no units; equivalent to molecular wt) |
|
MABP/MAP |
mean arterial blood pressure (no need to change MAP to MABP) |
|
MDCK cell line |
Madin-Darby canine kidney cell line |
|
me |
methylene (e.g. a,b-meATP) |
|
Me |
methyl (e.g. 2MeSATP = 2-methylthioATP) |
|
MEPC |
miniature endplate current |
|
MEPP |
miniature endplate potential |
|
mEPSP or MEPSP |
miniature EPSP |
|
minK |
K+ channel protein |
|
MSH |
melanocyte-stimulating hormone |
|
MVC |
maximum voluntary contraction |
|
MVJ |
myocardial O2 consumption (minute volume; clinical usage) |
|
MW |
molecular weight (NB no units) |
|
N |
normal (small capitals) |
|
N G, N v |
G = guanidino (modern, common form); v= the last (older more precise form); either acceptable |
|
Nai+, Nao+ |
intra- or extracellular Na+ |
|
NA |
noradrenaline |
|
n.a. |
not applicable |
|
NANC |
non-adrenergic, non-cholinergic |
|
n.d. |
not determined |
|
NEM |
N-ethylmaleimide |
|
NG108-15 |
mouse neuroblastoma –rat glioma cell line |
|
nH, NH |
Hill coefficient (subscript optional) |
|
NMDG |
N-methyl-D-glucamine |
|
OD |
optical density |
|
ORF |
open reading frame (molecular biology) |
|
P |
posterior (brain co-ordinate) |
|
P |
pressure |
|
P |
permeability |
|
P0 |
maximal isometric tension (subscript zero) |
|
Po or Popen |
open probability (subscripts ‘oh’ or open) |
|
Pa,CO2 |
arterial partial pressure of CO2 |
|
PA,CO2 |
alveolar partial pressure of CO2 |
|
PET,O2 |
end-tidal partial pressure of O2 |
|
Ptp |
transpulmonary pressure |
|
P1, P2 |
purinergic receptors |
|
Pi |
inorganic phosphate |
|
PAS |
periodic acid–Schiff reagent |
|
PCr |
phosphocreatine |
|
PCV |
packed cell volume (haematocrit) |
|
PD |
potential difference |
|
pD2 |
_log EC50 |
|
PDBu |
4-phorbol 12,13-dibutyrate |
|
PDE |
phosphodiesterase |
|
PEEP |
positive end-expiratory pressure |
|
PhD |
no stops |
|
PHS |
Public Health Service (of USA) |
|
PG |
prostaglandin |
|
pK |
_log of dissociation constant (also pKa; ‘a’ stands for acid) |
|
PKA |
protein kinase A (or cAMP-dependent protein kinase) |
|
PKC |
protein kinase C |
|
PMSF |
phenylmethylsulfonyl fluoride |
|
pNa1 or PNa |
sodium permeability |
|
PPST |
pre- and post-stimulus time (histogram) |
|
PQR |
complex heart waves (ECG) |
|
P.R. |
per rectum |
|
PSP |
postsynaptic potential |
|
PSS |
physiological saline (salt) solution |
|
PSTH |
post- or peristimulus time histogram |
|
PtdI |
phosphatidylinositol |
|
PtdI-P2 |
phosphatidylinositol 4,5-bisphosphate |
|
PTX |
pertussis toxin |
|
PVC |
polyvinylchloride |
|
Q |
charge entering a cell through a channel, measured in coulombs, e.g. QNMDA is the charge entering the cell |
|
|
through the NMDA channel |
|
QRS complex |
heart waves (ECG) |
|
R |
universal gas constant |
|
R- (also R-(+)-) |
indicates chiral configuration of a molecule |
|
Rin |
input resistance |
|
Rmin |
fluorescence ratio in absence of Ca2+ |
|
Rmax |
fluorescence ratio in presence of saturating Ca2+ |
|
RACE |
rapid amplification of cDNA ends (molecular biology) |
|
RBC |
red blood cell |
|
RBF |
renal blood flow |
|
RC |
circuit resistance–capacitance circuit |
|
REM |
rapid eye movement (sleep) |
|
Rh |
rhodopsin |
|
Rh 123 |
rhodamine 123 |
|
RIA |
radioimmunoassay |
|
RLIE |
reference liquid ion exchanger |
|
r.m.s./RMS |
root mean square |
|
RMP |
resting membrane potential (no need to change to Vrest etc.) |
|
RQ |
respiratory quotient |
|
R–R interval |
heart period, interval between successive R waves of the ECG |
|
R.S.D. |
residual standard deviation (small capitals) |
|
s or S |
slope factor |
|
S- (also S-(_)-) |
indicates chiral configuration of a molecule |
|
Sa,O2 |
arterial O2 saturation |
|
SCC |
short-circuit current (see current) |
|
SCG |
superior cervical ganglion |
|
SCT |
spinocervical tract |
|
SEM |
scanning electron microscope |
|
SERCA |
sarco(endo)plasmic reticulum Ca2+-ATPase |
|
SIT |
camera silicon intensified camera |
|
SNGFR |
single-nephron GFR |
|
SNP |
sodium notroprusside |
|
SP |
substance P |
|
SR |
sarcoplasmic reticulum |
|
SSC |
saline–sodium citrate buffer |
|
SSPE |
standard sodium phosphate EDTA |
|
STA |
spike-triggered average |
|
STPD |
standard temperature and pressure, dry |
|
STX |
saxitoxin |
|
t |
time |
|
T |
threshold (e.g. 5T) |
|
T |
absolute temperature |
|
T84 |
human cell line |
|
tpeak |
time to peak |
|
TBE |
Tris-borate-EDTA (buffer) |
|
CA |
trichloroacetic acid |
|
TLC |
thin-layer chromatography |
|
TMA |
tetramethylammonium |
|
Trizma |
tradename for Tris (Sigma) |
|
TTL |
transistor–transistor logic |
|
UNaV |
absolute sodium excretion |
|
V |
potential (also E for equilibrium potentials) |
|
V |
velocity |
|
V or V* |
may be used for mid-point potential in Boltzmann equation |
|
V50 |
membrane potential at 50 % inactivation |
|
Vc |
command potential ◊E expiratory flow |
|
Vh |
holding potential; sometimes VH; do not allow HP |
|
Vm |
membrane potential (see also Em) |
|
V0 |
maximum velocity of shortening (muscle fibres) (subscript zero) |
|
VO2 |
consumption rate |
|
VCO2 |
CO2 production rate |
|
Vrev |
reversal potential |
|
VT |
tidal volume |
|
WT |
wild-type |
|
z |
valency in Boltzmann equation |
|
Z- |
indicates molecular configuration |
|
Ψm |
mitochondrial membrane potential |
|
γ |
single-channel conductance |
|
λ |
wavelength of light |
|
Δ |
change in or of. . . e.g. ΔHR = change in heart rate |
|
Π |
osmotic pressure |
|
2-D |
two dimensional |
|
3-D |
three dimensional |
|
3T3 cells |
common mouse cell line |